Quirke / Marijnen / Nagtegaal / Martling / New York / Stockholm / Washington / DC / Auckland / Muttillo / Karanjia / Mohamdee / London / /
Company
Blackwell Science Ltd. / Dutch ColoRectal Cancer Group / Cox / McCall / MEDLINE / /
Country
Germany / Netherlands / Italy / Sweden / Norway / France / Austria / United States / United Kingdom / Ireland / Denmark / / /
Event
FDA Phase / /
Facility
Auckland Hospital / Mary’s Hospital / /
IndustryTerm
therapy of rectal cancer / cancer therapy / treatment of primary rectal cancer / treatment of middle and lower third rectal cancers / treatment of rectal cancer / imaging / therapy for patients with N2 disease / treatment of cancer / treatment of these cancers / cement / therapy for rectal cancer / /
MedicalCondition
JE / colorectal cancer / metastasis / rectal carcinoma / dysfunction / lower third rectal cancers / carcinoma / rectal cancer / adenocarcinoma / tumor / cancer / disease / cancer of the sigmoid / Cancer of the Rectum / rectal tumors / extensive aggressive cancer / Rectal Cancer Paul F. Ridgway / gastrointestinal dysfunction / carcinomas / metastases / /
MedicalTreatment
radiation therapy / adjuvant chemotherapy / cancer surgery / chemotherapy / radiotherapy / surgical treatment / surgery / cancer therapy / adjuvant radiotherapy / adjunctive therapy / drainage / Adjuvant therapy / /
MusicGroup
Color / /
Organization
Department of Surgical Oncology and Technology / Imperial College Faculty of Medicine / Division of Surgery / Anaesthetics and Intensive Care / St. Mary’s Hospital / /
Person
Ann Surg / Ara W. Darzi / J. J. Mahany / Jr. / Arch Surg / Paul F. Ridgway / Ernest Miles / Paul Ziprin / Ann Med / Ann Surg Oncol / Steven Dowsett / /
Total mesorectal excision is now the gold standard adjunctive surgical therapy